CD58 Emerges as a Central Player in How Tumors Evade Immune Attack and Resist Therapy
A new review in Molecular Cancer details how loss of the immune synapse molecule CD58 drives tumor immune evasion and ...
A new review in Molecular Cancer details how loss of the immune synapse molecule CD58 drives tumor immune evasion and ...
A new review in Molecular Cancer positions patient-derived organoids as living systems for mapping how cancers tolerate, persist through, and ...
New research identifies the enzyme CYP2S1 as a driver of immunosuppressive cell recruitment and poor chemoimmunotherapy response in esophageal squamous ...
A new review in Nature Reviews Clinical Oncology details how the tumour extracellular matrix, or matrisome, drives cancer progression and ...
A selective dual T-cell activator directed at the TCR beta chain revives exhausted antitumor T cells and sensitizes checkpoint-resistant cancers ...
A new review maps how secreted protein circuits in gastrointestinal tumours govern immune recruitment, suppression and response to checkpoint immunotherapy.
New research shows that lung adenocarcinoma cells package the protein SPP1 into extracellular vesicles to reprogram fibroblasts into an MMP11-positive ...
A new review in the Journal of Translational Medicine details how the RNA methyltransferase METTL3 drives tumor immune escape through ...
A new review explains why IDO1 inhibitors often fail, revealing that tumors and tissues compensate by rerouting tryptophan metabolism through ...
A new review synthesizes decades of evidence showing that selective COX-2 inhibitors can suppress tumor initiation, growth and immunotherapy resistance ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine